{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:49:20Z","timestamp":1775789360012,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 22H04922"],"award-info":[{"award-number":["JP 22H04922"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004031","name":"Jichi Medical University","doi-asserted-by":"publisher","award":["16H05460"],"award-info":[{"award-number":["16H05460"]}],"id":[{"id":"10.13039\/501100004031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neuropharm.2025.110819","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:55:37Z","timestamp":1767167737000},"page":"110819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spinal Shati\/nat8l regulates mechanical hyperalgesia through NAAG-mGluR3 signaling in neuropathic pain"],"prefix":"10.1016","volume":"287","author":[{"given":"Keisuke","family":"Miyamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Tatsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-0456","authenticated-orcid":false,"given":"Kyosuke","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Tokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3185-7790","authenticated-orcid":false,"given":"Shin-ichi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-5045","authenticated-orcid":false,"given":"Naotaka","family":"Izuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4232-1657","authenticated-orcid":false,"given":"Kazuhiko","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsumi","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4108-2500","authenticated-orcid":false,"given":"Masahiro","family":"Ohsawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110819_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pain.2005.07.017","article-title":"Role of peripheral group I and II metabotropic glutamate receptors in IL-1\u03b2-induced mechanical allodynia in the orofacial area of conscious rats","volume":"118","author":"Ahn","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110819_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2010.04.008","article-title":"Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme : implications for specialized acetyl coenzyme A metabolism in the CNS","volume":"1335","author":"Ariyannur","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110819_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2010.04.008","article-title":"Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme : implications for specialized acetyl coenzyme A metabolism in the CNS","volume":"1335","author":"Ariyannur","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110819_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1023\/A:1023250721185","article-title":"N-acetylaspartate in the vertebrate brain: metabolism and function","volume":"28","author":"Baslow","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2025.110819_bib5","doi-asserted-by":"crossref","first-page":"29156","DOI":"10.1074\/jbc.M110.111765","article-title":"Molecular characterization of N-acetylaspartylglutamate synthetase","volume":"285","author":"Becker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110819_bib6","doi-asserted-by":"crossref","first-page":"29156","DOI":"10.1074\/jbc.M110.111765","article-title":"Molecular characterization of N-acetylaspartylglutamate synthetase","volume":"285","author":"Becker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110819_bib7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nrd2999","article-title":"Targeting protein kinases in central nervous system disorders","volume":"8","author":"Chico","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2025.110819_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110819_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110819_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2012.08.028","article-title":"Absence of SHATI\/Nat8l reduces social interaction in mice","volume":"526","author":"Furukawa-Hibi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110819_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092696","article-title":"Recent advances in pain management: relevant protein kinases and their inhibitors","volume":"26","author":"Giraud","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2025.110819_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/npr2.12068","article-title":"Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex","volume":"39","author":"Haddar","year":"2019","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.neuropharm.2025.110819_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110819_bib14","first-page":"1","article-title":"Visualization of brain activity in a neuropathic pain model using quantitative activity-dependent manganese magnetic resonance imaging","volume":"13","author":"Inami","year":"2019","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2025.110819_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"Ji","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110819_bib16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bph.13740","article-title":"Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2\/3 receptor agonist LY2934747, in rodent pain models","volume":"174","author":"Johnson","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110819_bib17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bph.13740","article-title":"Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2\/3 receptor agonist LY2934747, in rodent pain models","volume":"174","author":"Johnson","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2025.110819_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2005.05.008","article-title":"Analgesic effects of the selective group II (mGlu2\/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing","volume":"49","author":"Jones","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110819_bib19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2010.05.004","article-title":"Retinoid X receptor gamma control of affective behaviors involves dopaminergic signaling in mice","volume":"66","author":"Krzy\u017cosiak","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110819_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jpain.2013.04.015","article-title":"Long-term antidepressant treatment inhibits neuropathic pain-induced CREB and PLC\u03b3-1 phosphorylation in the mouse spinal cord dorsal horn","volume":"14","author":"Kusuda","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2025.110819_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/glia.23474","article-title":"Astrocyte-neuron lactate shuttle sensitizes nociceptive transmission in the spinal cord","volume":"67","author":"Miyamoto","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2025.110819_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1017\/S146114571400011X","article-title":"Overexpression of Shati\/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice","volume":"17","author":"Miyamoto","year":"2014","journal-title":"Int. J. Neuropsychopharmacol.\/Off Scientific J. Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"key":"10.1016\/j.neuropharm.2025.110819_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnene.2013.00011","article-title":"N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation","volume":"5","author":"Moffett","year":"2013","journal-title":"Front. Neuroenerg."},{"key":"10.1016\/j.neuropharm.2025.110819_bib24","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.neuropharm.2006.07.018","article-title":"Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration","volume":"51","author":"Nagel","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110819_bib25","first-page":"477","article-title":"The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia","volume":"26","author":"Neale","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110819_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-4159.2011.07338.x","article-title":"Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family","volume":"118","author":"Neale","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110819_bib27","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1523\/JNEUROSCI.1575-07.2007","article-title":"A novel molecule \u201c Shati \u201d is involved in Methamphetamine- induced hyperlocomotion , sensitization , and conditioned place preference","volume":"27","author":"Niwa","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110819_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(00)00571-9","article-title":"Involvement of spinal protein kinase C in thermal hyperalgesia evoked by partial sciatic nerve ligation, but not by inflammation in the mouse","volume":"403","author":"Ohsawa","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110819_bib29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.bjp.0704583","article-title":"Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo","volume":"135","author":"Sharpe","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110819_bib30","article-title":"Neuropathic pain; what we know and what we should do about it","volume":"4","author":"Smith","year":"2023","journal-title":"Front Pain Res. (Lausanne, Switzerland)"},{"key":"10.1016\/j.neuropharm.2025.110819_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1745-7254.2005.00123.x","article-title":"Activation of ERK\/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats","volume":"26","author":"Song","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2025.110819_bib32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/WNR.0000000000000416","article-title":"Induction of neuronal axon outgrowth by Shati\/Nat8l by energy metabolism in mice cultured neurons","volume":"26","author":"Sumi","year":"2015","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2025.110819_bib33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1017\/S1461145713001302","article-title":"Deletion of SHATI\/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence","volume":"17","author":"Toriumi","year":"2014","journal-title":"Int. J. Neuropsychopharmacol.\/Off Scientific J. Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"key":"10.1016\/j.neuropharm.2025.110819_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0174196","article-title":"Methamphetamine induces Shati\/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism","volume":"12","author":"Uno","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110819_bib35","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110819_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2012.01.019","article-title":"CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [3H]LY459477 autoradiography","volume":"66","author":"Wright","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110819_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1471-4159.1997.69010174.x","article-title":"N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells","volume":"69","author":"Wroblewska","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110819_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1460-9568.2004.03504.x","article-title":"Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110819_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1460-9568.2004.03504.x","article-title":"Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110819_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1460-9568.2006.05272.x","article-title":"Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats","volume":"25","author":"Yamamoto","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110819_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1460-9568.2006.05272.x","article-title":"Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats","volume":"25","author":"Yamamoto","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110819_bib42","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1523\/JNEUROSCI.22-15-06388.2002","article-title":"Peripheral Group II metabotropic glutamate receptors (mGluR2\/3) regulate prostaglandin E 2 -Mediated sensitization of Capsaicin responses and thermal nociception","volume":"22","author":"Yang","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825005271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825005271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:04:36Z","timestamp":1775786676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825005271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":42,"alternative-id":["S0028390825005271"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110819","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal Shati\/nat8l regulates mechanical hyperalgesia through NAAG-mGluR3 signaling in neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110819"}}